Mainz Biomed B.V. (MYNZ )

Currency in USD Disclaimer
$6.68 +$1.91 (40.04%)
Closed 12/20/2024
$5.19
$7.22
$0.18
$7.95

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol MYNZ
  • Company Mainz Biomed B.V.
  • Price $6.68
  • Changes Percentage 40.04
  • Change 1.91
  • Day Low $5.19
  • Day High $7.22
  • Year High $7.95
  • Year Low $0.18
  • Market Cap $13,376,700
  • Price Avg 50 EMA (D) $1.68
  • Price Avg 200 EMA (D) $0.86
  • Exchange NASDAQ
  • Volume 660,400
  • Average Volume 3,122,617
  • Open $5.24
  • Previous Close $4.77
  • EPS -44.4
  • PE -0.15
  • Earnings Announcement 2025-04-07 12:00:00
  • Shares Outstanding $2,002,500

Company brief: MAINZ BIOMED B.V. (MYNZ )

Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.

MYNZ Corporation News

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test

Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test

December 19, 2024 at 1:01 pm ET

globenewswire.com -- BERKELEY, Calif. and MAINZ, Germany, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V....

Income Statement